TN2014000340A1 - Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors - Google Patents
Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitorsInfo
- Publication number
- TN2014000340A1 TN2014000340A1 TNP2014000340A TN2014000340A TN2014000340A1 TN 2014000340 A1 TN2014000340 A1 TN 2014000340A1 TN P2014000340 A TNP2014000340 A TN P2014000340A TN 2014000340 A TN2014000340 A TN 2014000340A TN 2014000340 A1 TN2014000340 A1 TN 2014000340A1
- Authority
- TN
- Tunisia
- Prior art keywords
- oxazolidin
- compounds
- inhibitors
- pi3k
- pi3ks
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108091007960 PI3Ks Proteins 0.000 abstract 3
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 abstract 3
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 abstract 3
- 230000001419 dependent effect Effects 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to oxazolidin-2-one subsituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736707P | 2012-12-13 | 2012-12-13 | |
| PCT/IB2013/051443 WO2013124826A1 (en) | 2012-02-24 | 2013-02-22 | Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2014000340A1 true TN2014000340A1 (en) | 2015-12-21 |
Family
ID=53365644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2014000340A TN2014000340A1 (en) | 2012-12-13 | 2014-08-06 | Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| CU (1) | CU20140102A7 (en) |
| TN (1) | TN2014000340A1 (en) |
-
2014
- 2014-08-06 TN TNP2014000340A patent/TN2014000340A1/en unknown
- 2014-08-21 CU CU2014000102A patent/CU20140102A7/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CU20140102A7 (en) | 2014-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501900A1 (en) | Oxazolidin-2-one compounds and uses thereof as pi3ks inhibitors | |
| IN2015DN02912A (en) | ||
| MX2015012502A (en) | Dna-pk inhibitors. | |
| CA2871471C (en) | Dna-pk inhibitors | |
| PH12016501160A1 (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| EA024842B9 (en) | Compounds as modulators of pi3k protein kinase | |
| GEP20196983B (en) | Heteroaryls and uses thereof | |
| MD20150071A2 (en) | Azabenzimidazole compounds as inhibitors of PDE4 isozymes for the treatment of CNS and other disorders | |
| PH12016502291A1 (en) | Indolizine derivatives as phosphoinositide 3-kinases inhibitors | |
| MX376090B (en) | Chromene derivatives as phoshoinositide 3-kinases inhibitors | |
| PH12017500595A1 (en) | Aldosterone synthase inhibitors | |
| TN2014000340A1 (en) | Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors | |
| AU2012312301A8 (en) | Compounds useful as inhibitors of choline kinase |